#Michael Carwile

[genevieveetguy]

Classical Period, Ted Fendt (2018)

[blockheadbrands]

Ohio Experts Withdraw Recommendation to Approve Cannabis for Autism, Anxiety

A.J. Herrington of High Times Reports:

The full board will have a vote in September.

A committee of experts advising regulators in Ohio has withdrawn its recommendation to approve adding autism and anxiety as qualifying conditions for the state’s medical marijuana program. The action by the Ohio Medical Marijuana Control Program’s expert review panel on Wednesday follows a recommendation to approve the two conditions for inclusion in the program the committee issued in May.

After hearing additional testimony from four physicians and reviewing several letters opposed to the plan on Wednesday, the committee voted to reverse the earlier decision.

Dr. Michael Schottenstein, the president of the Ohio State Medical Board, is a psychiatrist practicing in the Columbus area. He is also a member of the review committee and opposed adding autism and anxiety to the state’s list of qualifying conditions.

“Approval feels premature at this time,” Schottenstein said after the committee voted to reverse course. “For the medical board, there should be consensus to do so among respected medical authorities.”

Committee member Robert Giacalone was also opposed to approving the recommendation.

“There is, at best, anecdotal evidence on the other side,” he said.

“The comfort’s just not there,” Giacalone added. “I’m hearing solid science on one side and, at best, anecdotal science on the other.”

Doctors Disagree on Proposal

Anup Patel, the section chief of neurology at Nationwide Children’s Hospital in Columbus, said that there is anecdotal evidence that suggests cannabis may be an effective treatment for autism and anxiety. But with no clinical trials showing that medical marijuana was safe and effective, Patel advised against adding the conditions to Ohio’s program.

“The reality is we should all still be held to the same standard of the scientific method,” he said.

Three other physicians also testified against adding anxiety and autism as qualifying conditions. Additionally, the board had received letters against the proposal from Cincinnati Children’s Hospital Medical Center, the Ohio Children’s Hospital Association, the Ohio Psychiatric Physicians Association, and the Ohio departments of Health and Mental Health and Addiction Services.

Gary Wenk, a professor of psychology at Ohio State University who studies how drugs affect the brain, was one of two physicians who supported adding anxiety and autism as qualifying conditions for the state’s medical marijuana program He said that some research on animals suggests that cannabis can aid neural development and reduce incidents of self-harm in autistic children.

“I came down on the side of saying this is useful,” Wenk said.

Mom Left in Tears by Decision

Tiffany Carwile of Bryan, Ohio submitted the petition to add autism as a qualifying condition because she believes that medical marijuana could help her 5-year-old son. She was in tears on Wednesday after hearing of the committee’s decision to rescind the recommendation for approval.

“The medications our kids have access to now are absolutely horrible in comparison to cannabis,” Carwile said. “I am so heartbroken for Ohio. I am truly shaken to the core.”

The full state medical board is expected to vote on adding anxiety and autism to Ohio’s list of qualifying conditions at its next meeting on September 11. The board voted against adding depression, opioid abuse disorder, and insomnia in May while delaying the decision on anxiety and autism so new board members could be brought up to speed on the issues.

TO READ MORE OF THIS ARTICLE ON HIGH TIMES, CLICK HERE.

https://hightimes.com/news/ohio-experts-withdraw-recommendation-approve-cannabis-autism-anxiety/

[weedconsortium2]

A committee of experts advising regulators in Ohio has withdrawn its recommendation to approve adding autism and anxiety as qualifying conditions for the state’s medical marijuana program. The action by the Ohio Medical Marijuana Control Program’s expert review panel on Wednesday follows a recommendation to approve the two conditions for inclusion in the program the committee issued in May.

After hearing additional testimony from four physicians and reviewing several letters opposed to the plan on Wednesday, the committee voted to reverse the earlier decision.

Dr. Michael Schottenstein, the president of the Ohio State Medical Board, is a psychiatrist practicing in the Columbus area. He is also a member of the review committee and opposed adding autism and anxiety to the state’s list of qualifying conditions.

“Approval feels premature at this time,” Schottenstein said after the committee voted to reverse course. “For the medical board, there should be consensus to do so among respected medical authorities.”

Committee member Robert Giacalone was also opposed to approving the recommendation.

“There is, at best, anecdotal evidence on the other side,” he said.

“The comfort’s just not there,” Giacalone added. “I’m hearing solid science on one side and, at best, anecdotal science on the other.”

Doctors Disagree on Proposal

Anup Patel, the section chief of neurology at Nationwide Children’s Hospital in Columbus, said that there is anecdotal evidence that suggests cannabis may be an effective treatment for autism and anxiety. But with no clinical trials showing that medical marijuana was safe and effective, Patel advised against adding the conditions to Ohio’s program.

“The reality is we should all still be held to the same standard of the scientific method,” he said.

Three other physicians also testified against adding anxiety and autism as qualifying conditions. Additionally, the board had received letters against the proposal from Cincinnati Children’s Hospital Medical Center, the Ohio Children’s Hospital Association, the Ohio Psychiatric Physicians Association, and the Ohio departments of Health and Mental Health and Addiction Services.

Gary Wenk, a professor of psychology at Ohio State University who studies how drugs affect the brain, was one of two physicians who supported adding anxiety and autism as qualifying conditions for the state’s medical marijuana program He said that some research on animals suggests that cannabis can aid neural development and reduce incidents of self-harm in autistic children.

“I came down on the side of saying this is useful,” Wenk said.

Mom Left in Tears by Decision

Tiffany Carwile of Bryan, Ohio submitted the petition to add autism as a qualifying condition because she believes that medical marijuana could help her 5-year-old son. She was in tears on Wednesday after hearing of the committee’s decision to rescind the recommendation for approval.

“The medications our kids have access to now are absolutely horrible in comparison to cannabis,” Carwile said. “I am so heartbroken for Ohio. I am truly shaken to the core.”

The full state medical board is expected to vote on adding anxiety and autism to Ohio’s list of qualifying conditions at its next meeting on September 11. The board voted against adding depression, opioid abuse disorder, and insomnia in May while delaying the decision on anxiety and autism so new board members could be brought up to speed on the issues.

The post Ohio Experts Withdraw Recommendation to Approve Cannabis for Autism, Anxiety appeared first on High Times.

The post Ohio Experts Withdraw Recommendation to Approve Cannabis for Autism, Anxiety appeared first on CBD Oil Vape Liquid Spray - Cbd Pain Relief Capsules - Weed Consortium.

from WordPress https://ift.tt/30fZrWQ via IFTTT

[blockheadbrands]

Ohio Medical Board Rejects Addition of Depression to Medical Marijuana Program

A.J. Herrington of High Times Reports:

The State Medical Board of Ohio rejected a proposal on Wednesday that would have added depression, opioid addiction, and insomnia to the list of conditions that qualify a patient for the state’s medical marijuana program. The board also decided to delay a vote on including anxiety and autism as qualifying conditions until new members of the body have a chance to review the evidence presented.

Last month, a board advisory committee met to consider adding the five medical conditions to the state’s medicinal cannabis program. Medical experts presenting evidence to the panel generally concurred that research supported the use of medical marijuana as a treatment for autism and anxiety, but disagreed on treating opioid addiction, depression, and insomnia with cannabis. The committee subsequently recommended that that the full board vote to add anxiety and autism and reject the proposals for the other three conditions.

Board President Dr. Michael Schottenstein suggested postponing the vote on adding anxiety and autism until two new members of the board have had an opportunity to review more than 2,000 pages of evidence from medical experts supporting the use of cannabis to treat autism and anxiety. A date for the vote by the full board has not yet been set, but it could occur as soon as the next meeting in July, according to media reports.

‘No Rush’ to Add New Conditions

Schottenstein said during the meeting on Wednesday that there is “no rush” to approve the proposals.

“I’m swallowing hard to even consider indications for medical marijuana for these conditions, given the very real concerns that I have about this drug,” he said. “So if I have the time to educate myself or to hear from additional experts, to meet about it, and to either solidify my opinion or to provoke second thoughts, I’m glad for that.”

The Ohio law that legalized the medicinal use of cannabis in 2016 included 21 medical conditions including cancer, epilepsy, Parkinson’s disease, and glaucoma that qualify a patient to access the state’s program. The measure also included an apparatus for the public to petition for new conditions to be added to the program on a yearly basis. Ohio’s medical marijuana currently has about 31,000 registered patients.

Moms Still Hopeful

Tiffany Carwile, the Ohio state director for the national medicinal cannabis activist group Mothers Advocating Medical Marijuana for Autism, said that she was disappointed that the board has delayed the vote but expressed optimism that the new members will carefully review the evidence.

“I hope that they take into consideration the thousands of lives that this (decision) affects, not just for autism and anxiety but for the multitudes of people who will seek and get relief from medical cannabis without the cocktail of pharmaceuticals,” said Carwile.

TO READ MORE OF THIS ARTICLE ON HIGH TIMES, CLICK HERE.

https://hightimes.com/news/ohio-medical-board-rejects-addition-depression-medical-marijuana-program/